Martin Shkreli US Supreme Court Rejects Martin Shkreli's Appeal
The former pharmaceutical executive sought to appeal a $64.6 million judgement issued against him for inflating drug cost and trying to stifle generics from launching.
October 07, 2024 at 04:43 PM
3 minute read
White Collar Crime
The U.S. Supreme Court on Monday declined to hear the appeal of former pharmaceutical executive Martin Shkreli that sought to wriggle him out of a $64.6 million judgment for inflating the price of a life-saving drug.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 4The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 5Elder Litigators Confront Tough Questions in Last Act of Careers
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
